These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 540072
21. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)]. Dauverchain J. Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956 [Abstract] [Full Text] [Related]
22. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro. Avcu F, Ural AU, Cetin T, Nevruz O. Thromb Res; 2008; 121(4):567-71. PubMed ID: 17910980 [Abstract] [Full Text] [Related]
24. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C. Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038 [Abstract] [Full Text] [Related]
25. Quantitative assessment of polymerized and depolymerized platelet microtubules. Changes caused by aggregating agents. Steiner M, Ikeda Y. J Clin Invest; 1979 Mar 19; 63(3):443-8. PubMed ID: 429563 [Abstract] [Full Text] [Related]
26. [Platelet anti-aggregating activity of furosemide (author's transl)]. Garcia-Conde J, Merino J, Golpe JA, Benet I. Rev Esp Fisiol; 1976 Dec 19; 32(4):269-74. PubMed ID: 1005885 [Abstract] [Full Text] [Related]
27. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation. Siess W, Roth P, Weber PC. Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338 [Abstract] [Full Text] [Related]
28. Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure. Walford T, Musa FI, Harper AG. Br J Pharmacol; 2016 Jan 30; 173(1):234-47. PubMed ID: 26450366 [Abstract] [Full Text] [Related]
29. [Effect of heparin on platelet aggregation in vitro]. Róka L, Isert D. Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Jan 30; 111(6):735-49. PubMed ID: 6083949 [Abstract] [Full Text] [Related]
30. Differential effect of retinoic acid on ADP and collagen induced platelet aggregation. Mukherjee G, Chatterjee GC, Banerjee D, Bhattacharya DK. Indian J Exp Biol; 1990 Oct 30; 28(10):949-52. PubMed ID: 2279767 [Abstract] [Full Text] [Related]
31. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen. Fiedel BA, Gewurz H. J Immunol; 1976 Oct 30; 117(4):1073-8. PubMed ID: 977942 [Abstract] [Full Text] [Related]
32. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase. Pericin D, Leskovac V. Arzneimittelforschung; 1981 Oct 30; 31(12):2082-5. PubMed ID: 6277342 [Abstract] [Full Text] [Related]
35. Effect of ergolines on neurotransmitter systems in the rat brain. Moretti A, Carfagna N, Caccia C, Carpentieri M. Arch Int Pharmacodyn Ther; 1988 Oct 30; 294():33-45. PubMed ID: 2906797 [Abstract] [Full Text] [Related]
37. Effect of an alpha-blocking agent, nicergoline, on the interaction between blood platelets, elastin and endothelial cells. Rafelson ME, Migne J, Santonja R, Derouette JC, Robert L. Biochem Pharmacol; 1980 Mar 15; 29(6):943-7. PubMed ID: 7387709 [No Abstract] [Full Text] [Related]